Avalon GloboCare Corp. Files 8-K
Ticker: ALBT · Form: 8-K · Filed: Aug 28, 2025 · CIK: 1630212
Sentiment: neutral
Topics: 8-k, disclosure, financials
Related Tickers: AVLO
TL;DR
AVLO filed an 8-K on 8/28/25 - check for Reg FD and financial exhibits.
AI Summary
Avalon GloboCare Corp. filed an 8-K on August 28, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or details about the nature of the disclosures or exhibits.
Why It Matters
This filing indicates that Avalon GloboCare Corp. has made a regulatory disclosure and submitted financial exhibits, which could contain important updates for investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for disclosures and exhibits, with no immediate indication of significant negative events.
Key Players & Entities
- Avalon GloboCare Corp. (company) — Registrant
- August 28, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 001-38728 (commission_file_number) — SEC File Number
- 47-1685128 (ein) — I.R.S. Employer Identification Number
- 4400 Route 9 South, Suite 3100, Freehold, NJ 07728 (address) — Principal executive offices
- (732) 780-4400 (phone_number) — Registrant's telephone number
FAQ
What specific information was disclosed under Regulation FD?
The filing does not specify the content of the Regulation FD disclosure.
What types of financial statements and exhibits were filed?
The filing indicates that financial statements and exhibits were filed, but does not detail their nature.
When was the report filed?
The report was filed on August 28, 2025.
What is the company's principal executive office address?
The principal executive offices are located at 4400 Route 9 South, Suite 3100, Freehold, NJ 07728.
What is the company's SEC file number?
The SEC file number is 001-38728.
Filing Stats: 559 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2025-08-28 10:10:26
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share ALBT The Nasdaq Capital M
Filing Documents
- ea025468401-8k_avalon.htm (8-K) — 25KB
- ea025468401ex99-1_avalon.htm (EX-99.1) — 16KB
- ex99-1_001.jpg (GRAPHIC) — 10KB
- 0001213900-25-081433.txt ( ) — 222KB
- albt-20250828.xsd (EX-101.SCH) — 3KB
- albt-20250828_lab.xml (EX-101.LAB) — 33KB
- albt-20250828_pre.xml (EX-101.PRE) — 22KB
- ea025468401-8k_avalon_htm.xml (XML) — 4KB
01. Financial Statement and Exhibits
Item 9.01. Financial Statement and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release of the Company dated August 28, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVALON GLOBOCARE CORP. Dated: August 28, 2025 By: /s/ Luisa Ingargiola Name: Luisa Ingargiola Title: Chief Financial Officer 2